Overview of Molecular Diagnostics in Clinical Pathology

作者: H. Fernandes , P. Zhang

DOI: 10.1016/B978-0-12-386456-7.06306-1

关键词:

摘要: Molecular diagnostics has expanded medical genomics in a major way. assays complement results obtained from serology, microbiology, and hematology tests. They provide supplemental information to anatomical pathologists for the diagnosis classification of cancers. Oncologists use mutation analysis molecular select first-line therapy cancers rely on specialized tests prognostic assessment residual tumor cells that may still be present very small amounts after – minimal disease. Infectious disease specialists diagnosis, monitoring, therapeutic management patients. Clinical geneticists depend data screening inherited rare diseases. Technologically advanced interrogate an array genetic variants microorganisms panel-like interpretation host genome diseases steer clinicians toward personalized approach patient management. This technology-driven discipline utilizes principle complementarity amplify, hybridize, sequence DNA. Development, verification, validation as well training personnel testing are critical establishing performance characteristics diagnostics.

参考文章(45)
Louis Hlousek, Sergey Voronov, Vesselin Diankov, Amy B. Leblang, Patrick J. Wells, Donna M. Ford, Jork Nolling, Kyle W. Hart, Patricio A. Espinoza, Michael R. Bristol, Gregory J. Tsongalis, Belinda Yen-Lieberman, Vladimir I. Slepnev, Lilly I. Kong, Ming-Chou Lee, Automated high multiplex qPCR platform for simultaneous detection and quantification of multiple nucleic acid targets. BioTechniques. ,vol. 52, pp. 316- 324 ,(2012) , 10.2144/0000113852
Iris Schrijver, Nazneen Aziz, Daniel H. Farkas, Manohar Furtado, Andrea Ferreira Gonzalez, Timothy C. Greiner, Wayne W. Grody, Tina Hambuch, Lisa Kalman, Jeffrey A. Kant, Roger D. Klein, Debra G.B. Leonard, Ira M. Lubin, Rong Mao, Narasimhan Nagan, Victoria M. Pratt, Mark E. Sobel, Karl V. Voelkerding, Jane S. Gibson, Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology. The Journal of Molecular Diagnostics. ,vol. 14, pp. 525- 540 ,(2012) , 10.1016/J.JMOLDX.2012.04.006
Julie Di Cristofaro, Monique Silvy, Jacques Chiaroni, Pascal Bailly, Single PCR Multiplex SNaPshot Reaction for Detection of Eleven Blood Group Nucleotide Polymorphisms: Optimization, Validation, and One Year of Routine Clinical Use The Journal of Molecular Diagnostics. ,vol. 12, pp. 453- 460 ,(2010) , 10.2353/JMOLDX.2010.090222
Jin Li, G. Mike Makrigiorgos, COLD-PCR: a new platform for highly improved mutation detection in cancer and genetic testing Biochemical Society Transactions. ,vol. 37, pp. 427- 432 ,(2009) , 10.1042/BST0370427
Gregory J Tsongalis, A reality check for molecular diagnostics in clinical practice. Pharmacogenomics. ,vol. 4, pp. 667- 668 ,(2003) , 10.1517/PHGS.4.5.667.23800
Mark G Herrmann, Jacob D Durtschi, L Kathryn Bromley, Carl T Wittwer, Karl V Voelkerding, Instrument comparison for heterozygote scanning of single and double heterozygotes: a correction and extension of Herrmann et al., Clin Chem 2006;52:494-503. Clinical Chemistry. ,vol. 53, pp. 150- 152 ,(2007) , 10.1373/CLINCHEM.2006.081240
Milko B Kermekchiev, Anatoly Tzekov, Wayne M Barnes, Cold-sensitive mutants of Taq DNA polymerase provide a hot start for PCR Nucleic Acids Research. ,vol. 31, pp. 6139- 6147 ,(2003) , 10.1093/NAR/GKG813
Jan Stenvang Jepsen, Mads D. Sørensen, Jesper Wengel, Locked nucleic acid: a potent nucleic acid analog in therapeutics and biotechnology. Oligonucleotides. ,vol. 14, pp. 130- 146 ,(2004) , 10.1089/1545457041526317